| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | Pseudo-UTP |
| 5' Cap | Cap 1 |
| Species | Human |
| RefSeq | NM_001136.5 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 177 |
| UniProt ID | Q15109 |
| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | Pseudo-UTP |
| 5' Cap | Cap 1 |
| Species | Human |
| RefSeq | NM_001136.5 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 177 |
| UniProt ID | Q15109 |
| Download |
|---|
| Download resources about mRNA therapeutics development to boost your research. |
| CUSTOMER REVIEWS and Q&As | |
|---|---|
|
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AGER, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK11096MR). Click the button above to contact us or submit your feedback about this product. |
|
| See other products | |||
|---|---|---|---|
| CAT | Product Name | Product Type | CDs |
| GTTS-WK6652MR | IVTScrip™ mRNA-Human CD319, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) | mRNA | CD319 |
| GTTS-WK6937MR | IVTScrip™ mRNA-Human LAG3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) | mRNA | LAG3 |
| GTTS-WK1120MR | IVTScrip™ mRNA-Human IgD, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) | mRNA | IgD |
| GTTS-WK3337MR | IVTScrip™ mRNA-Human LAG3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) | mRNA | LAG3 |
| GTTS-WK1555MR | IVTScrip™ mRNA-Human CD4, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) | mRNA | CD4 |
| GTTS-WK16459MR | IVTScrip™ mRNA-Human ANXA2P2, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) | mRNA | ANXA2P2 |
| GTTS-WK6553MR | IVTScrip™ mRNA-Human CD28, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) | mRNA | CD28 |
| GTTS-WK0097MR | IVTScrip™ mRNA-Human CD276, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) | mRNA | CD276 |